• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓释特布他林与普通沙丁胺醇治疗支气管哮喘的比较

A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.

作者信息

Beskow R, Ericsson C H, Grönneberg R, Sjögren I, Skedinger M

出版信息

Eur J Respir Dis. 1984 Oct;65(7):509-11.

PMID:6386512
Abstract

The effects of a sustained-release preparation of terbutaline, depot tablets, 7.5 mg 2 times/day were compared with ordinary salbutamol tablets 4 mg 3 times/day. The study, performed for 2 weeks, one week on each treatment, was double-blind, double-dummy, crossover with randomized allocation of the drugs. Twenty-five patients with chronic bronchial asthma completed the trial. The morning Peak-Flow was higher during the period on the depot tablets compared to that on the ordinary tablets (p less than 0.05). No differences were found in side effects.

摘要

将特布他林缓释制剂(长效片,7.5毫克,每日2次)与普通沙丁胺醇片(4毫克,每日3次)的效果进行了比较。该研究为期2周,每种治疗各进行1周,采用双盲、双模拟、随机分配药物的交叉试验。25例慢性支气管哮喘患者完成了试验。与服用普通片剂期间相比,服用长效片期间的晨间呼气峰流速更高(p<0.05)。在副作用方面未发现差异。

相似文献

1
A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma.缓释特布他林与普通沙丁胺醇治疗支气管哮喘的比较
Eur J Respir Dis. 1984 Oct;65(7):509-11.
2
A comparison of sustained-release terbutaline and ordinary terbutaline in bronchial asthma.
Br J Dis Chest. 1982 Apr;76(2):202-4.
3
Nocturnal asthma: slow-release terbutaline versus slow-release theophylline therapy.
Eur Respir J. 1988 Apr;1(4):306-10.
4
Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.规律吸入β-受体激动剂治疗期间的支气管扩张剂耐受性和反跳性支气管收缩
Respir Med. 2000 Aug;94(8):767-71. doi: 10.1053/rmed.2000.0820.
5
Terbutaline depot tablets in asthma. A clinical evaluation.喘乐宁长效片治疗哮喘的临床评价
Allergy. 1981 Oct;36(7):495-500. doi: 10.1111/j.1398-9995.1981.tb01861.x.
6
Terbutaline sustained-release tablets in nocturnal asthma--a placebo-controlled comparison between a high and a low evening dose.
Br J Dis Chest. 1988 Jul;82(3):237-41. doi: 10.1016/0007-0971(88)90063-0.
7
Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily.一种新型每日一次的支气管扩张药物班布特罗与每日两次的特布他林缓释剂的比较。
Eur Respir J. 1988 Mar;1(3):223-6.
8
Terbutaline slow-release tablets in children with asthma. A comparison with t.i.d. beta 2-agonist therapy.特布他林缓释片用于儿童哮喘。与每日三次使用β2激动剂疗法的比较。
Allergy. 1986 Jul;41(5):331-4. doi: 10.1111/j.1398-9995.1986.tb00309.x.
9
[Salmeterol improves the control of disease in patients with moderate asthma. A comparative study of inhaled salmeterol 50 mg and salbutamol depot tablets 8 mg, both administered twice daily].沙美特罗可改善中度哮喘患者的疾病控制情况。一项吸入50毫克沙美特罗与8毫克沙丁胺醇长效片的对比研究,二者均每日给药两次
Ugeskr Laeger. 1996 Jul 1;158(27):3940-3.
10
Terbutaline depot tablets in childhood asthma. A double-blind controlled study.特布他林长效片用于儿童哮喘。一项双盲对照研究。
Allergy. 1985 Oct;40(7):497-500. doi: 10.1111/j.1398-9995.1985.tb00256.x.

引用本文的文献

1
North of England evidence based guidelines development project: summary version of evidence based guideline for the primary care management in adults.英格兰北部循证指南制定项目:成人初级保健管理循证指南概要版
BMJ. 1996 Mar 23;312(7033):762-6. doi: 10.1136/bmj.312.7033.762.
2
Salbutamol in the 1980s. A reappraisal of its clinical efficacy.20世纪80年代的沙丁胺醇。对其临床疗效的重新评估。
Drugs. 1989 Jul;38(1):77-122. doi: 10.2165/00003495-198938010-00004.